The Healthcare Technology Report is your comprehensive source for business news, investment activity and corporate actions related to the software and SaaS sectors
Live Last read · last published · next check
Only 12% to 17% of patients remain compliant with physical therapy programs. When Arpit Khemka learned how many people were requesting surgery, imaging, or opioids for pain that could often be managed through physical therapy, he began looking for a better way to deliver care...
A complex patient’s medical history can arrive as 300 or 400 pages of faxed PDFs—leaving clinical staff to sort, categorize, and enter the information before the appointment. Predoc Founder and CEO Nishant Hari saw this burden firsthand through his wife, a physician who encountered cumbersome record-retrieval workflows at every stage of her career, from medical school to practice...
One in five Americans currently faces a mental health challenge. For the clinicians treating them, that can mean a massive amount of compliance and regulatory paperwork that eats up time better spent with patients. At Qualifacts, CEO Josh Schoeller’s answer has been to bring the AI work in-house. His team built an AI ambient listening tool from scratch in just four months, which now translates…
The "time is brain" mantra is well-known in stroke care. Viz.ai is built for what happens when the clock is ticking: turning AI detection into faster clinical action. Jieun Choe, Chief Operating Officer of Viz.ai, joined the company when AI was still a foreign concept to many, leaving a stable executive role after seeing the platform used in a hospital setting. Today, Viz.ai serves over 2,000…
Orthopedic care is easy to underestimate until you look closely at what recovery actually requires. Bracing, cold therapy, and post-surgical support may sit outside the most closely watched corners of medtech, but they shape how patients heal and how providers manage care every day...
Aging shows up in obvious ways—slower recovery, less strength, reduced mobility—but Hans Keirstead argues that one of the root causes sits deeper in the immune system. As Chairman of the Board at Immunis, he is building therapies around the idea that age-related muscle loss is tied to immune decline, and that treating it may require something far broader than a traditional single-target drug...
Specialty care often comes down to a timing problem. Hospitals may know what kind of physician a patient needs, but they often cannot get that specialist involved quickly enough to keep care moving. Meena Mallipeddi, Co-Founder and CEO of AmplifyMD, saw that specialty access was being constrained by both physician shortages and workflow inefficiencies...
Medication risk compounds faster than most care teams can track it. In this episode, Brad Margolis, CEO of MDI Health, explains how polypharmacy has made medication management a growing clinical and financial challenge. The number of older adults taking five or more medications has tripled over the past two decades, raising the risk of serious side effects and making complex regimens harder for…
AI can design molecules. Who makes them? In this episode, Yann Gaston-Mathé, Co-Founder and CEO of Iktos, explains why generative models alone won’t speed up drug discovery. The slow part often comes after the model outputs a molecule: someone still has to synthesize it, test it, and feed the results back into the next round of design. When that step moves slowly, everything else slows with it...
Healthcare has no shortage of data. It has a shortage of trust in that data. Dan Riskin, Chief Executive Officer of Verantos, traces that problem back to a question Congress asked during the 21st Century Cures effort: what could derail AI in healthcare? He pointed to data quality. If routinely collected data produces the wrong answer today, scaling AI means scaling the harm...